Tower Research Capital LLC (TRC) - PHIO PHARMACEUTICALS CORP ownership

Back to all holdings Add to watchlist

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 12 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2022$2
-99.9%
5,220
-4.5%
0.00%–
Q3 2022$3,000
-50.0%
5,465
-33.2%
0.00%–
Q2 2022$6,000
+200.0%
8,183
+1096.3%
0.00%–
Q2 2021$2,000
+100.0%
684
+17.7%
0.00%–
Q3 2020$1,000–581–0.00%–
 Download
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
VANGUARD GROUP INC 154,536$57,4870.00%
UBS Group AG 23,029$8,5210.00%
TWO SIGMA INVESTMENTS, LP 22,398$8,3320.00%
Cetera Investment Advisers 75,000$27,9000.00%
WELLS FARGO & COMPANY/MN 93$350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 106,917$390.00%
MORGAN STANLEY 1,500$5580.00%
BlackRock Inc. 19$70.00%
TWO SIGMA SECURITIES, LLC 19,707$7,3310.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders